Welcome to LookChem.com Sign In|Join Free
  • or
R-METHYL 1-CBZ-PIPERIDINE-2-CARBOXYLATE is a chemical compound that is widely used in the pharmaceutical industry for the synthesis of various drugs. It is a derivative of piperidine and carboxylic acid, known for its potential to act as a central nervous system depressant and has been extensively studied for its pharmacological properties.
Used in Pharmaceutical Industry:
R-METHYL 1-CBZ-PIPERIDINE-2-CARBOXYLATE is used as an intermediate in the production of antihistamines, antipsychotics, and analgesics for its role in the synthesis of these therapeutic medications.
Used in Central Nervous System Depressant Research:
R-METHYL 1-CBZ-PIPERIDINE-2-CARBOXYLATE is used as a subject of research for its potential to act as a central nervous system depressant, which can contribute to the development of medications targeting neurological disorders and mental health conditions.
Used in Neurological Disorders and Mental Health Research:
R-METHYL 1-CBZ-PIPERIDINE-2-CARBOXYLATE is used as a compound of interest in the investigation of its potential use in the treatment of neurological disorders and mental health conditions, due to its pharmacological properties.

60369-19-9

Post Buying Request

60369-19-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

60369-19-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 60369-19-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,0,3,6 and 9 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 60369-19:
(7*6)+(6*0)+(5*3)+(4*6)+(3*9)+(2*1)+(1*9)=119
119 % 10 = 9
So 60369-19-9 is a valid CAS Registry Number.

60369-19-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-O-benzyl 2-O-methyl (2R)-piperidine-1,2-dicarboxylate

1.2 Other means of identification

Product number -
Other names R-METHYL 1-CBZ-PIPERIDINE-2-CARBOXYLATE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:60369-19-9 SDS

60369-19-9Relevant academic research and scientific papers

Chemoenzymatic synthesis, structural study and biological activity of novel indolizidine and quinolizidine iminocyclitols

Gómez, Livia,Garrabou, Xavier,Joglar, Jesús,Bujons, Jordi,Parella, Teodor,Vilaplana, Cristina,Cardona, Pere Joan,Clapés, Pere

experimental part, p. 6309 - 6321 (2012/09/05)

The synthesis, conformational study and inhibitory properties of diverse indolizidine and quinolizidine iminocyclitols are described. The compounds were chemo-enzymatically synthesized by two-step aldol addition and reductive amination reactions. The aldol addition of dihydroxyacetone phosphate (DHAP) to N-Cbz-piperidine carbaldehyde derivatives catalyzed by l-rhamnulose 1-phosphate aldolase from Escherichia coli provides the key intermediates. The stereochemical outcome of both aldol addition and reductive amination depended upon the structure of the starting material and intermediates. The combination of both reactions furnished five indolizidine and six quinolizidine type iminocyclitols. A structural analysis by NMR and in silico density functional theory (DFT) calculations allowed us to determine the population of stereoisomers with the trans or cis ring fusion, as a consequence of the inversion of configuration of the bridgehead nitrogen. The trans fusion was by far the most stable, but for certain stereochemical configurations of the 3-hydroxymethyl and hydroxyl substituents both trans and cis fusion stereoisomers coexisted in different proportions. Some of the polyhydroxylated indolizidines and quinolizidines were shown to be moderate to good inhibitors against α-l-rhamnosidase from Penicillium decumbens. Indolizidines were found to be moderate inhibitors of the rat intestinal sucrase and of the exoglucosidase amyloglucosidase from Aspergillus niger. In spite of their activity against α-l-rhamnosidase, all the compounds were ineffective to inhibit the growth of the Mycobacterium tuberculosis, the causative agent of tuberculosis. The Royal Society of Chemistry 2012.

Electrochemical deallylation of α-allyl cyclic amines and synthesis of optically active quaternary cyclic amino acids

Kirira, Peter G.,Kuriyama, Masami,Onomura, Osamu

experimental part, p. 3970 - 3982 (2010/07/04)

Electrochemical oxidation of α-allylated and α-betizylated N-acylated cyclic amines by using a graphite anode easily affords the corresponding α-methoxylated products with up to 76% yield. Ease of oxidation was affected by the type of electrode, the size

An efficient synthesis of sulfamides

Guo, Chuangxing,Dong, Liming,Kephart, Susan,Hou, Xinjun

scheme or table, p. 2909 - 2913 (2010/06/14)

Here we report an efficient synthesis of sulfamides. 3,5-Lutidine was found to be an optimal solvent and catalyst for the reaction. The method was developed during our efforts to synthesize a series of novel FKBP-12 inhibitors in which the known ketoamide linker was replaced with sulfamide.

Effecient kinetic resolution of racemic amino aldehydes by oxidation with N-iodosuccinimide

Minato, Daishirou,Nagasue, Yoko,Demizu, Yosuke,Onomura, Osamu

supporting information; experimental part, p. 9458 - 9461 (2009/05/06)

(Chemical Equation Presented) Selective recognition: The first efficient method for the kinetic resolution of racemic amino aldehydes (see scheme, PG=protecting group) is based on a copper(II)/(R,R)-Ph-BOX complex. The coordinated amino aldehydes were tra

Caspase inhibitors and uses thereof

-

, (2008/06/13)

The present invention relates to novel classes of compounds of formula I which are caspase and TNF-alpha inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of th

Caspase inhibtors and uses thereof

-

, (2008/06/13)

This invention provides caspase inhibitors having the formula wherein Ring A is an optionally substituted piperidine, tetrahydroquinoline or tetrahydroisoquinoline ring; R1 is hydrogen, CHN2, R, or —CH2Y; R is an optionall

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 60369-19-9